These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 16690926)

  • 41. Different roles of Sp family members in HIV-1 Tat-mediated manganese superoxide dismutase suppression in hepatocellular carcinoma cells.
    Porntadavity S; Nath A; Prachayasittikul V; Cota-Gomez A; Flores SC; St Clair DK
    DNA Cell Biol; 2005 May; 24(5):299-310. PubMed ID: 15869407
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Functional roles for the TATA promoter and enhancers in basal and Tat-induced expression of the human immunodeficiency virus type 1 long terminal repeat.
    Berkhout B; Jeang KT
    J Virol; 1992 Jan; 66(1):139-49. PubMed ID: 1727476
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The human immunodeficiency virus type 1 long terminal repeat specifies two different transcription complexes, only one of which is regulated by Tat.
    Lu X; Welsh TM; Peterlin BM
    J Virol; 1993 Apr; 67(4):1752-60. PubMed ID: 8445708
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differential role of long terminal repeat control elements for the regulation of basal and Tat-mediated transcription of the human immunodeficiency virus in stimulated and unstimulated primary human macrophages.
    Moses AV; Ibanez C; Gaynor R; Ghazal P; Nelson JA
    J Virol; 1994 Jan; 68(1):298-307. PubMed ID: 8254741
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An in vitro transcription system that recapitulates equine infectious anemia virus tat-mediated inhibition of human immunodeficiency virus type 1 Tat activity demonstrates a role for positive transcription elongation factor b and associated proteins in the mechanism of Tat activation.
    Suñé C; Goldstrohm AC; Peng J; Price DH; Garcia-Blanco MA
    Virology; 2000 Sep; 274(2):356-66. PubMed ID: 10964778
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of SWI/SNF chromatin remodeling complex on HIV-1 Tat activated transcription.
    Agbottah E; Deng L; Dannenberg LO; Pumfery A; Kashanchi F
    Retrovirology; 2006 Aug; 3():48. PubMed ID: 16893449
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intracellular human immunodeficiency virus Tat expression in astrocytes promotes astrocyte survival but induces potent neurotoxicity at distant sites via axonal transport.
    Chauhan A; Turchan J; Pocernich C; Bruce-Keller A; Roth S; Butterfield DA; Major EO; Nath A
    J Biol Chem; 2003 Apr; 278(15):13512-9. PubMed ID: 12551932
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Activation of a heterologous promoter by human immunodeficiency virus type 1 Tat requires Sp1 and is distinct from the mode of activation by acidic transcriptional activators.
    Kamine J; Subramanian T; Chinnadurai G
    J Virol; 1993 Nov; 67(11):6828-34. PubMed ID: 8411386
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Induction of Sp1 phosphorylation and NF-kappa B-independent HIV promoter domain activity in T lymphocytes stimulated by okadaic acid.
    Vlach J; Garcia A; Jacqué JM; Rodriguez MS; Michelson S; Virelizier JL
    Virology; 1995 Apr; 208(2):753-61. PubMed ID: 7747447
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Human immunodeficiency viruses containing heterologous enhancer/promoters are replication competent and exhibit different lymphocyte tropisms.
    Chang LJ; McNulty E; Martin M
    J Virol; 1993 Feb; 67(2):743-52. PubMed ID: 8419644
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The human immunodeficiency virus-1 Tat protein increases cell proliferation, alters sensitivity to zinc chelator-induced apoptosis, and changes Sp1 DNA binding in HeLa cells.
    Seve M; Favier A; Osman M; Hernandez D; Vaitaitis G; Flores NC; McCord JM; Flores SC
    Arch Biochem Biophys; 1999 Jan; 361(2):165-72. PubMed ID: 9882443
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regulation of the human immunodeficiency virus type 1 long terminal repeat: interactions of thyroid hormone receptor with retinoid-X receptor, nuclear factor kappa B, Sp1, and Tat.
    Desai-Yajnik V; Samuels HH
    Trans Assoc Am Physicians; 1993; 106():13-32. PubMed ID: 8036737
    [No Abstract]   [Full Text] [Related]  

  • 53. HIV-1 regulatory protein tat induces RNA binding proteins in central nervous system cells that associate with the viral trans-acting-response regulatory motif.
    Kundu M; Ansari SA; Chepenik LG; Pomerantz RJ; Khalili K; Rappaport J; Amini S
    J Hum Virol; 1999; 2(2):72-80. PubMed ID: 10225209
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Exon2 of HIV-2 Tat contributes to transactivation of the HIV-2 LTR by increasing binding affinity to HIV-2 TAR RNA.
    Rhim H; Rice AP
    Nucleic Acids Res; 1994 Oct; 22(21):4405-13. PubMed ID: 7971271
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication.
    Beauparlant P; Kwon H; Clarke M; Lin R; Sonenberg N; Wainberg M; Hiscott J
    J Virol; 1996 Sep; 70(9):5777-85. PubMed ID: 8709193
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Latency-associated nuclear antigen encoded by Kaposi's sarcoma-associated herpesvirus interacts with Tat and activates the long terminal repeat of human immunodeficiency virus type 1 in human cells.
    Hyun TS; Subramanian C; Cotter MA; Thomas RA; Robertson ES
    J Virol; 2001 Sep; 75(18):8761-71. PubMed ID: 11507221
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Functional differences between human and bovine immunodeficiency virus Tat transcription factors.
    Bogerd HP; Wiegand HL; Bieniasz PD; Cullen BR
    J Virol; 2000 May; 74(10):4666-71. PubMed ID: 10775603
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A quantitative GFP-based bioassay for the detection of HIV-1 Tat transactivation inhibitors.
    Daelemans D; De Clercq E; Vandamme AM
    J Virol Methods; 2001 Aug; 96(2):183-8. PubMed ID: 11445148
    [TBL] [Abstract][Full Text] [Related]  

  • 59. C/EBP- and Tat-mediated activation of the HIV-1 LTR in CD34+ hematopoietic progenitor cells.
    Quiterio S; Grant C; Hogan TH; Krebs FC; Wigdahl B
    Biomed Pharmacother; 2003 Jan; 57(1):49-56. PubMed ID: 12642037
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Human immunodeficiency virus type 1 Tat activity in human neuronal cells: uptake and trans-activation.
    Kolson DL; Collman R; Hrin R; Balliet JW; Laughlin M; McGann KA; Debouck C; Gonzalez-Scarano F
    J Gen Virol; 1994 Aug; 75 ( Pt 8)():1927-34. PubMed ID: 8046394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.